drugset / Trial / NCT01499017
A Single Dose Study Of PF-06291874 In Healthy Adult Subjects
RandomizedCrossoverDouble-blind
Summary
The primary purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of PF-06291874 in healthy volunteers.
Timeline
- Start
- 2011-11
- Primary completion
- 2012-01
- Completion
- 2012-01
Outcome
Outcome not reported
Stopped: “See termination reason in detailed description.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06291874 | Small molecule | 3 mg | Oral |
| Subject | PF-06291874 | Small molecule | 100 mg | Oral |
| Subject | PF-06291874 | Small molecule | 300 mg | Oral |
| Subject | PF-06291874 | Small molecule | 650 mg | Oral |
Indications
No indication recorded.